Archived
Loading...
0
score
Unranked
About this Topic
▾
Treace Medical Concepts, Inc. (NASDAQ:TMCI) reported five-year results from the ALIGN3D study for the Lapiplasty bunion-correction procedure. The analysis included 137 of 173 treated patients across seven U.S. sites and 13 surgeons. Radiographic recurrence was reported at 0.8% for a hallux valgus angle greater than 20 degrees and 5.3% for an angle greater than 15 degrees.
The findings provide data on the durability of the three-dimensional correction and stabilization provided by Lapiplasty. While the data offers a foundation for surgeon education, the company reported second-quarter revenue of $45.4 million with a GAAP net loss of $15.9 million.
The findings provide data on the durability of the three-dimensional correction and stabilization provided by Lapiplasty. While the data offers a foundation for surgeon education, the company reported second-quarter revenue of $45.4 million with a GAAP net loss of $15.9 million.